drugset
drugset / Trial / NCT05279768

Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.

NCT05279768 ↗

Phase 1/2 Completed 44 enrolled PT. Prodia Stem Cell Indonesia
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to investigating the effect of Umbilical Cord Mesenchymal Stem Cell (UC-MSCs) and secretomes to insulin resistance in Polycystic Ovary Syndrome (PCOS) patients. This study has 4 arms namely UC-MSCs treatment, secretomes treatment, UC-MSCs and secretomes treatment, and control.

Timeline

Start
2022-09-01
Primary completion
2025-01-20
Completion
2025-01-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Secretomes Unknown 0.5 ml Intranasal
Subject mesenchymal stem cells Cell therapy 0.3 unknown Intravenous
Comparator Metformin Small molecule — —

Indications

polycystic ovary syndrome